Clearwater Capital Advisors, LLC Amgen Inc Transaction History

Clearwater Capital Advisors, LLC

$892 Million
Q1 2024

A detailed history of Clearwater Capital Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Clearwater Capital Advisors, LLC holds 1,859 shares of AMGN stock, worth $577,925. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,859

Previous 1,872 0.69%

Holding current value

$577,925

Previous $539,000 2.04%

% of portfolio

0.06%

Previous 0.06%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$268.87 - $324.56 $3,495 - $4,219	-13 Reduced 0.69%	1,859 $528,000
Q4 2023 Feb 06, 2024	BUY	$255.7 - $288.46 $17,643 - $19,903	69 Added 3.83%	1,872 $539,000
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $6,773 - $8,256	-30 Reduced 1.64%	1,803 $435,000
Q4 2022 Jan 27, 2023	SELL	$229.03 - $291.01 $3,206 - $4,074	-14 Reduced 0.76%	1,833 $0
Q3 2022 Nov 01, 2022	SELL	$224.46 - $253.15 $8,080 - $9,113	-36 Reduced 1.91%	1,847 $416,000

Q2 2022 Jul 21, 2022	BUY	$230.71 - $256.74 $11,535 - $12,837	50 Added 2.73%	1,883 $458,000
Q2 2021 Aug 04, 2021	SELL	$233.58 - $259.14 $233 - $259	-1 Reduced 0.05%	1,833 $447,000
Q4 2020 Jan 21, 2021	BUY	$216.38 - $257.67 $216 - $257	1 Added 0.05%	1,834 $422,000
Q2 2020 Jul 30, 2020	SELL	$197.81 - $242.74 $4,945 - $6,068	-25 Reduced 1.35%	1,833 $432,000
Q1 2020 Apr 15, 2020	SELL	$182.24 - $241.7 $9,294 - $12,326	-51 Reduced 2.67%	1,858 $377,000
Q4 2019 Jan 27, 2020	SELL	$189.21 - $243.2 $3,594 - $4,620	-19 Reduced 0.99%	1,909 $460,000
Q4 2018 Jan 22, 2019	SELL	$178.4 - $208.25 $12,488 - $14,577	-70 Reduced 3.5%	1,928 $375,000
Q3 2018 Oct 17, 2018	SELL	$185.29 - $208.89 $53,548 - $60,369	-289 Reduced 12.64%	1,998 $414,000
Q2 2017 Aug 11, 2017	BUY	N/A	2,287	2,287 $394,000

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearwater Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearwater Capital Advisors, LLC with notifications on news.

Account

Clearwater Capital Advisors, LLC Amgen Inc Transaction History